Synthetic Biology is a branch discipline that just appeared in the 21st century in Biological Science . In recent years, the research on synthetic biological matter has made rapid progress. Synthetic biology is different from traditional biology’s methods of dissecting living organisms to study their internal structures. The research direction of synthetic biology is completely opposite. It starts with the most basic elements and establishes parts step by step.
is divided from the perspective of upstream and downstream of the industrial chain. The upstream empowers various technologies and the downstream is various product application companies.
Synthetic Biology Industry Chain
Source: Compiled by Zhiyan Consulting
Synthetic Biotechnology has developed into a full supplement and substitution of traditional technologies, and is widely used in terminal fields such as medical, chemical, food, agriculture, and consumer goods. As of the end of 2021, the global synthetic biology-related market industry has grown explosively, with the market size reaching US$73.693 billion, an increase of 767.5% over 2021.
Global synthetic biology market size and growth from 2016 to 2021 (unit: million US dollars)
Source: DeepTech, Zhiyan Consulting compiled
Among them: the most obvious growth is the medical field, with the market size reaching US$68.724 billion in 2021; followed by the chemical field, with the market size of synthetic biology US$1.822 billion; the market size of synthetic biology in the scientific research service field is US$1.811 billion; the market size of synthetic biology in the agricultural field is US$497 million; the market size of synthetic biology in the food field is US$508 million; the market size of synthetic biology in other fields is US$331 million.
2016-2021 global synthetic biology market size (unit: billion US dollars)
Source: DeepTech, Zhiyan Consulting compiled
It is predicted that with the continuous maturity of synthetic biology technology and corresponding policy stimulus, it is expected that by 2030-2040, 60% of the global economic material investment will be generated by biology (including synthetic biology), and the output value space that will affect will reach 1.8-3.6 trillion US dollars; it is estimated that from 2040-2050, 70% of the global economic material investment will be generated by biology (including synthetic biology), and the output value space that will affect will reach 3.0-5.1 trillion US dollars, with broad development prospects in the industry.
The economic impact of the future of global biology
Source: McKinsey Biological Revolution, Zhiyan Consulting and Organized
In just a few years, my country has entered the fast lane from basic research to industrial development, from underlying technologies to industrialized terminal products. The size of China's synthetic biology market in 2021 was approximately US$6.416 billion, an increase of US$3.938 billion from 2020.
2016-2021 China's synthetic biology market size and growth
Source: DeepTech, Zhiyan Consulting compiled
With the vigorous development of my country's synthetic biology students, it has attracted the favor of a lot of capital. In 2021, China Synthetic Biology received 16 investment and financing, an increase of 10 from 2020; the amount of financing received was 2.295 billion yuan, an increase of 136 million yuan from 2020.
2015-2021 China Synthetic Biology Investment and Financing Quantity and Financing
Source: IT Orange, Zhiyan Consulting compiled
From the perspective of the distribution of investment and financing rounds of synthetic biology, China Synthetic Biology obtained 3 financings in 2021, each of angel round, Pre-A round, and A round, and each of 2 financings in the B, B+ round, and C round, and once financings in the A+ round. In terms of financing amount, China Synthetic Biology received 93 million yuan in angel round financing in 2021; 180 million yuan in Pre-A round financing; 245 million yuan in round A round financing; 97 million yuan in round B round financing; 850 million yuan in round B round financing; 480 million yuan in round B round financing; 350 million yuan in round C round financing.
2021 China Synthetic Biology Investment and Financing Quantity and Amount Round Distribution
Source: IT Orange, Zhiyan Consulting Compiled
2021 and 2022, the capital financing obtained by China Synthetic Biology is all in the medical and health industry, involving new materials, biotechnology and html l3 Pharmaceutical sub-industry, and the companies that have received financing include Hibiscus Chemistry, Blue Crystal Microbiology, ChemicalAI Intelligent Technology, Enhe Biology, Yikelai Biology, Enhe Biology, Blue Crystal Microbiology, ChemicalAI Intelligent Technology, Hibiscus Chemistry, Shize Biology, Red Panda Biology, Weiming Shiguang Biology, Ketaiya Biology, Enhe Biology, Shize Biology, Shize Biology, Blue Crystal Microbiology, Microstructure Factory, Enhe Biology, Zeno Technology, Baiyin Biology, and Ketaiya Biology.
2020 China Synthetic Biology Investment and Financing Events
Source: IT Orange, Zhiyan Consulting Compiled
2021 China Synthetic Biology Investment and Financing Events
Source: IT Orange, Zhiyan Consulting Compiled
2022 China Synthetic Biology Investment and Financing Events
Source: IT Orange, Zhiyan Consulting Compiled
